Physician profile
Matthew V Capozzi
NPI 1821298241
$748.48
in general payments reported to CMS, 2019-2025
8 companies · $51.25 in 2025
The $51.25 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $263 · 2020: $174 · 2021: $17.50 · 2022: $101 · 2023: $94.71 · 2024: $46.68 · 2025: $51.25.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $193.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $192.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Wright Medical Technology, INC. | $238.14 | 2019-2020 | |
| Stryker Corporation | $177.59 | 2019-2025 | Prophecy, Ortholoc 2 Lapifuse, Prostep Mica |
| Bioventus LLC | $134.72 | 2021-2025 | Exogen Ultrasound Bone Healing System, Exogen Ultrasound Bone Healing System |
| Trilliant Surgical LLC. | $83.29 | 2019 | |
| Smith+Nephew, INC. | $57.19 | 2019-2025 | Collagenase Santyl, Iodosorb Ointment 40g USA, Regranex |
| Nevro Corp. | $29.02 | 2022 | |
| Zimmer Biomet Holdings, INC. | $16.42 | 2019 | |
| Acumed LLC | $12.11 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Capozzi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.